Page 9 - Personalised medicine of fluoropyrimidines using DPYD pharmacogenetics Carin Lunenburg
P. 9
Beyond current DPYD pharmacogenetics
Chapter 10
Chapter 11
Chapter 12
Comparison of four phenotyping assays for predicting 253 dihydropyrimidine dehydrogenase (DPD) deficiency and severe fluoropyrimidine-induced toxicity: a clinical study
Manuscript in preparation
Diagnostic and therapeutic strategy for fluoropyrimidine treatment of 279 patients carrying multiple DPYD variants
Genes 2018;9(12):585
Genome-wide association study to discover novel genetic variants 303 related to the onset of severe toxicity following fluoropyrimidine use
Manuscript in preparation
General discussion, summaries and appendix
Chapter 13 Chapter 14
Appendix
General discussion and future perspectives 321
Summary 341 Nederlandse samenvatting 345
List of publications 354 Courses and training activities 357 Curriculum vitae 359 Dankwoord 360
